Today's Reality in Alzheimer's Disease: Timely Detection, Collaborative Care and Real-World Impact

Key Takeaways

Timely and accurate Alzheimer’s disease (AD) diagnosis is critical for access to care planning, including potential treatment with disease-modifying therapies.
Strong patient-provider partnerships can enable timely assessment and treatment.
AD blood tests are expanding access to help aid in a timely diagnosis.
Amyloid-targeting therapies (ATTs) can help slow cognitive decline in patients with early symptomatic AD.
Early intervention and shared decision-making empower patients and can improve real-world outcomes.